All Stories

  1. The hybrid algorithm for chronic total occlusions
  2. Implementing a minimally invasive approach (combining radial approach, small guiding catheters and minimization of double access) for coronary chronic total occlusion intervention according to the hybrid algorithm: The Minimalistic Hybrid Algorithm
  3. A “minimalistic hybrid algorithm” in coronary chronic total occlusion revascularization: Procedural and clinical outcomes
  4. Incomplete coronary sinus reducer endothelialization as potential mechanism of clinical failure
  5. Impact of baseline cigarette smoking status on clinical outcome after transcatheter aortic valve replacement
  6. Ex Vivo Pilot Study of Cardiac Magnetic Resonance Velocity Mapping for Quantification of Aortic Regurgitation in a Porcine Model in the Presence of a Transcatheter Heart Valve
  7. Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent
  8. Evaluation of Cognitive Function Following Transcatheter Aortic Valve Replacement
  9. Clinical Implications of Distal Vessel Stenosis After Successful Coronary Chronic Total Occlusion Recanalization
  10. Postoperative Delirium in Individuals Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis
  11. Angiographic and clinical outcomes of antegrade versus retrograde techniques for chronic total occlusion revascularizations: Insights from the PRISON IV trial
  12. Impact of collateralisation to a concomitant chronic total occlusion in patients with ST-elevation myocardial infarction: a subanalysis of the EXPLORE randomised controlled trial
  13. Clinical outcomes of complex real-world diabetic patients treated with amphilimus sirolimus-eluting stents or zotarolimus-eluting stents: A single-center registry
  14. Very late migration to and retrieval of an Amplatzer patent foramen ovale occlusion device from the abdominal aortic carrefour
  15. Impact of ultra-thin struts on restenosis after chronic total occlusion recanalization: Insights from the randomized PRISON IV trial
  16. Hybrid transcatheter left ventricular reconstruction for the treatment of ischaemic cardiomyopathy
  17. Collateral Quality Decay Several Days After Primary Percutaneous Coronary Intervention
  18. Drug eluting balloon for the treatment of patients with coronary artery disease: Current perspectives
  19. First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusions with the hybrid algorithm
  20. Subadventitial stenting around occluded stents: A bailout technique to recanalize in-stent chronic total occlusions
  21. The SABRE Trial (Sirolimus Angioplasty Balloon for Coronary In-Stent Restenosis)
  22. Fully Transradial Versus Transfemoral Approach for Percutaneous Intervention of Coronary Chronic Total Occlusions Applying the Hybrid Algorithm
  23. Optical coherence tomography findings: insights from the “randomised multicentre trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chr...
  24. Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention Through Ipsilateral Collateral Channels
  25. Antegrade Dissection and Reentry as Part of the Hybrid Chronic Total Occlusion Revascularization Strategy
  26. Rationale and design of amphilimus sirolimus-eluting stents versus zotarolimus-eluting stents in all-comers requiring percutaneous coronary intervention (ReCre8): A multicenter randomized clinical trial
  27. Towards a contemporary, comprehensive scoring system for determining technical outcomes of hybrid percutaneous chronic total occlusion treatment: The RECHARGE score
  28. Transradial versus transfemoral ancillary approach in complex structural, coronary, and peripheral interventions. Results from the multicenter ancillary registry: A study of the Italian Radial Club
  29. Evaluation of current practices in transcatheter aortic valve implantation: The WRITTEN (WoRldwIde TAVI ExperieNce) survey
  30. Transcatheter aortic valve implantation in low ejection fraction/low transvalvular gradient patients
  31. Special Technique and Case Illustrations of CTO Intervention via Transradial Approach
  32. Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total Occlusions
  33. TCT-721 Reverse Causality and Effect of Body Mass Index on Clinical Outcomes and all-Cause Mortality after Transcatheter Aortic Valve Replacement
  34. TCT-747 Effect of Transcatheter Aortic Valve Replacement on Mid-term Cognitive Outcome – A Prospective Pilot Study
  35. TCT-722 Clinical Effect of New Cerebral Ischemic Lesions on the Occurrence of Postoperative Delirium after Transcatheter Aortic Valve Implantation
  36. TCT-82 Evaluation of Current Practices in Transcatheter Aortic Valve Replacement: The WRITTEN (WoRldwIde TAVR ExperieNce) Survey
  37. The Hybrid Algorithm for Treating Chronic Total Occlusions in Europe
  38. Percutaneous Device to Narrow the Coronary Sinus: Shifting Paradigm in the Treatment of Refractory Angina? A Review of the Literature
  39. Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI
  40. Effect of New Cerebral Ischemic Lesions on the Delirium Occurrence After Transcatheter Aortic Valve Replacement
  41. Single transradial guide catheter retrograde/antegrade recanalization of a complex circumflex artery chronic total occlusion
  42. TriGuard™HDH embolic deflection device for cerebral protection during transcatheter aortic valve replacement
  43. IN-HOSPITAL OUTCOMES OF THE HYBRID ALGORITHM FOR CHRONIC TOTAL OCCLUSIONS: THE RECHARGE REGISTRY
  44. Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation
  45. How should I treat a chronic total occlusion of a saphenous vein graft? Successful retrograde revascularisation
  46. Incidence, Predictive Factors, and Effect of Delirium After Transcatheter Aortic Valve Replacement
  47. Kounis syndrome with cardiogenic shock during transfemoral transcatheter aortic valve replacement
  48. Effect of Drug-Coated Balloons in Native Coronary Artery Disease Left With a Dissection
  49. Myths to Debunk to Improve Management, Referral, and Outcomes in Patients With Chronic Total Occlusion of an Epicardial Coronary Artery
  50. Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis
  51. Interosseous artery collaterals and their support to ulno-palmar arch: A case report and a review of the literature
  52. TCT-409 Effect of drug-coated balloons in native coronary artery disease left with a dissection
  53. TCT-680 Pre-Procedural Work-up process In Patients Undergoing Transcatheter Aortic Valve Implantation: Results From The Written (WoRldwIde TAVI ExpieNce) Survey
  54. Women Undergoing Coronary Angiography for Myocardial Infarction or Who Present With Multivessel Disease Have a Poorer Prognosis Than Men
  55. Gender differences in health-related quality of life in patients undergoing coronary angiography
  56. Ethnicity Modifies Associations between Cardiovascular Risk Factors and Disease Severity in Parallel Dutch and Singapore Coronary Cohorts
  57. Inter-Ethnic Differences in Quantified Coronary Artery Disease Severity and All-Cause Mortality among Dutch and Singaporean Percutaneous Coronary Intervention Patients
  58. Severity of stable coronary artery disease and its biomarkers differ between men and women undergoing angiography
  59. Primary percutaneous coronary intervention by drug-eluting balloon angioplasty: The nonrandomized fourth arm of the DEB-AMI (drug-eluting balloon in ST-segment elevation myocardial infarction) trial
  60. An Injectable and Drug-loaded Supramolecular Hydrogel for Local Catheter Injection into the Pig Heart
  61. TCTAP C-073 The Reverse CART Technique Made Possible by Guideliner with Bilateral Trans-Radial Approach
  62. Comparison of Balloon-Expandable Versus Self-Expandable Valves for Transcatheter Aortic Valve Implantation in Patients With Low-Gradient Severe Aortic Stenosis and Preserved Left Ventricular Ejection Fraction
  63. Aspirin underuse, non-compliance or cessation: Definition, extent, impact and potential solutions in the primary and secondary prevention of cardiovascular disease
  64. Transcollateral retrograde diagnostic coronary angiogram — important therapeutic implications for an occluded arterial coronary artery bypass graft
  65. Similar anti-inflammatory effects of intracoronary and intravenous Abciximab during primary percutaneous coronary intervention
  66. Embrella embolic deflection device for cerebral protection during transcatheter aortic valve replacement
  67. Efficacy of a Device to Narrow the Coronary Sinus in Refractory Angina
  68. CRT-809 TriGuard™ HD Embolic Deflection Device For Cerebral Protection During Transcatheter Aortic Valve Replacement: Results: Of The Deflect II Trial
  69. CRT-168 Comparative Assessment Of The Antirestenotic Efficacy Of Two Paclitaxel Drug-eluting Balloons With Different Coatings In The Treatment Of In-stent Restenosis: Results Of The DEB-ISR Study.
  70. A “Simplified” culotte technique using two dedicated bifurcation stents and additional angiographic stent enhancement to treat a complex bifurcation lesion in non-ST segment elevation myocardial infarction with poor left ventricular function
  71. Silent ischemic brain lesions after transcatheter aortic valve replacement: lesion distribution and predictors
  72. Is There a Role for Drug-Eluting Balloons in Treatment of Acute Coronary Syndromes?
  73. Clinical validation of a novel software for quantitative analysis of coronary intravascular ultrasound
  74. Three-dimensional aortic root reconstruction derived from rotational angiography for transcatheter balloon-expandable aortic valve implantation guidance
  75. TCT-682 Clinical Advantage Of Adjunctive Intracardiac Echocardiography In Angiography-Guided Transcatheter Aortic Valve Implantation
  76. TCT-670 Volume and distribution of aortic valve calcium and implications for aortic regurgitation after transcatheter aortic valve implantation
  77. TCT-708 Predictors Of Left Ventricular Function Improvement After Transcatheter Aortic Valve Implantation In Patients With Moderate To Severe Left Ventricular Dysfunction
  78. Svelte integrated delivery system performance examined through diagnostic catheter delivery: The SPEED registry
  79. SEDUCEd by optical coherence tomography in drug-eluting balloon assessment
  80. Very late bioresorbable vascular scaffold thrombosis following discontinuation of antiplatelet therapy
  81. TCTAP C-023 An Amazing Experience of Aspiration Thrombectomy
  82. Meta‐analysis of bioabsorbable versus durable polymer drug‐eluting stents in 20,005 patients with coronary artery disease: An update
  83. How should I treat an asymptomatic enlarging giant saphenous vein graft aneurysm?
  84. Six-Month Healing of the Nonocclusive Coronary Anastomotic Connector in an Off-Pump Porcine Bypass Model
  85. Cerebral microembolism during transradial coronary angiography: Comparison between single and double catheter strategy
  86. TCT-843 Drug eluting balloon vs drug eluting stent in PCI: insights from a meta-analysis of 1462 patients.
  87. Drug eluting balloon versus drug eluting stent in percutaneous coronary interventions: Insights from a meta-analysis of 1462 patients
  88. Can we predict which patients with ST-elevation myocardial infarction benefit most from radial access? Evidence from frequentist and Bayesian meta-regressions of randomized trials
  89. Same wrist intervention via the cubital (ulnar) artery in case of radial puncture failure for percutaneous cardiac catheterization or intervention: The multicenter SWITCH registry
  90. Diagnostic accuracy of optical coherence tomography parameters in predicting in-stent hemodynamic severe coronary lesions: Validation against fractional flow reserve
  91. TCT-784 Transcatheter Aortic Valve Implantation In Patients With Severe Aortic Valve Stenosis and Large Aortic Annulus, Using the Self-Expanding 31-mm Medtronic CoreValve Prosthesis: First Clinical Experience
  92. Angiographic fate of side branch dissections in bifurcation lesions treated with a provisional single stenting strategy: A post‐hoc analysis of the international multicenter randomized DEBIUT study
  93. Optimisation of transcatheter aortic balloon-expandable valve deployment: the two-step inflation technique
  94. Reply: MDCT in TAVR for Better Implant Angle and Outcomes
  95. Right versus left radial artery access for coronary procedures: An international collaborative systematic review and meta-analysis including 5 randomized trials and 3210 patients
  96. Long-term clinical outcome after fractional flow reserve– versus angio-guided percutaneous coronary intervention in patients with intermediate stenosis of coronary artery bypass grafts
  97. Serial Morphological and Functional Assessment of Drug-Eluting Balloon for In-Stent Restenotic Lesions
  98. Clinical and angiographic outcomes following first-in-man implantation of a novel thin-strut low-profile fixed-wire stent: the Svelte Coronary Stent Integrated Delivery System first-in-man trial
  99. Placement of tryton side branch stent only; A new treatment strategy for Medina 0,0,1 coronary bifurcation lesions
  100. Optical Coherence Tomography Imaging of Acute Stent Thrombosis After Stentys Stent Implantation
  101. P2Y12 Inhibitors: Pharmacologic Mechanism and Clinical Relevance
  102. Oral anticoagulants for the secondary prevention of coronary heart disease
  103. A prospective “oversizing” strategy of the Edwards SAPIEN bioprosthesis: Results and impact on aortic regurgitation
  104. Automated 3D Analysis of Pre-Procedural MDCT to Predict Annulus Plane Angulation and C-Arm Positioning
  105. Atherosclerotic coronary plaque regression and the risk of adverse cardiovascular events: A meta-regression of randomized clinical trials
  106. Radial Versus Femoral Randomized Investigation in ST-Segment Elevation Acute Coronary Syndrome
  107. Biodegradable versus durable polymer drug eluting stents in coronary artery disease: Insights from a meta-analysis of 5834 patients
  108. Safety and Efficacy of the cobalt chromium PRO-Kinetik coronary stent system: Results of the MULTIBENE study
  109. TCT-400 Risk of Brain Injury During Diagnostic Coronary Angiography: Comparison Between Single and Double Catheter Strategy During Right Transradial Approach
  110. First Results of the DEB-AMI (Drug Eluting Balloon in Acute ST-Segment Elevation Myocardial Infarction) Trial
  111. First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions
  112. Optical coherence tomography assessment of early stent strut coverage in patients treated with a thin-strut bare cobalt-chromium stent coated with silicon carbide
  113. Drug‐Eluting Balloons and Bifurcations, a New Future for Treatment?
  114. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: Six-month angiographic and 12-month clinical results of th
  115. A prospective multicentre registry, evaluating real-world usage of the Tryton side branch stent: results of the E-Tryton 150/Benelux registry
  116. 6- MONTHS FOLLOW UP IN A REAL LIFE SITUATION AFTER RENAL DENERVATION
  117. Potential Pitfalls of Meta-Analyses of Observational Studies in Cardiovascular Research
  118. Percutaneous coronary interventions in saphenous vein grafts: the more things change, the more they stay the same
  119. Tools & Techniques: Percutaneous intervention of saphenous vein graft lesions
  120. Measuring and targeting aldosterone and renin in atherosclerosis—A review of clinical data
  121. Transcatheter aortic implantation of the Edwards-SAPIEN bioprosthesis: Insights on early benefit of TAVI on mitral regurgitation
  122. The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment
  123. Are propensity scores really superior to standard multivariable analysis?
  124. Agreement between adjusted indirect comparison and simplified network meta-analyses on prasugrel and ticagrelor (Reply to Passaro et al. — Int J Cardiol 2011)
  125. Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesions
  126. Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes
  127. Pushing wrist access to the limit
  128. Coronary bifurcation lesions treated with the drug-eluting balloon: a preliminary insight from the DEBIUT study
  129. CLINICAL RELEVANCE OF ISCHEMIC LARGE ANIMAL MODELS IN STEM CELL THERAPY; AN OVERVIEW AND META-ANALYSIS.
  130. Transradial access without preliminary allen test—letter of comment on Rhyne et al.
  131. Use of drug-eluting stents for chronic total occlusions: A systematic review and meta-analysis
  132. 147 TAVI with the Edwards-SAPIEN endoprosthesis: impact of a systematic “oversizing” policy on aortic regurgitation
  133. 140 Impact of TAVI with the Edwards-SAPIEN endoprosthesis on mitral regurgitation: results of a serial echocardiography assessment
  134. Drug-eluting balloons and bifurcations, a new future?
  135. International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences
  136. Stent thrombosis is not always stent thrombosis: De novo atherosclerosis in a stented coronary segment
  137. Drug eluting stents versus bare metal stents in the treatment of saphenous vein graft disease: a systematic review and meta-analysis
  138. Drug eluting stents versus bare metal stents in the treatment of saphenous vein graft disease: a systematic review and meta-analysis
  139. Late renal stent thrombosis
  140. Single- versus multiple-vessel stenting for patients with ST-elevation myocardial infarction: results from a 30,886-patient meta-analysis
  141. Percutaneous Coronary Intervention for the Treatment of Saphenous Vein Grafts
  142. Screening for proximal coronary artery anomalies with 3-dimensional MR coronary angiography
  143. Quantitative Coronary Angiography in the Current Era: Principles and Applications
  144. Transradial versus transfemoral approach for percutaneous coronary procedures
  145. Percutaneous revascularization strategies in a patient with previous coronary artery bypass surgery: Technical and patho-physiological insights
  146. Prognostic Significance of Small Troponin I Rise After a Successful Elective Percutaneous Coronary Intervention of a Native Artery
  147. The ProLimus trial: a prospective, non-randomised, multicentre trial to evaluate the safety and clinical performance of the pimecrolimus eluting stent system (ProGenic)
  148. Infragenicular Stent Implantation for Below-the-Knee Atherosclerotic Disease: Clinical Evidence From an International Collaborative Meta-Analysis on 640 Patients
  149. On the current epidemic outburst of meta-analytic rage in interventional cardiology
  150. Long-term effect of chronic oral anticoagulation: focus on coronary artery disease
  151. Reply to “A case of very late stent thrombosis after bare metal coronary stent implantation: A neglected complication”
  152. Rotational vs. standard coronary angiography: An image content analysis
  153. “Virtual” in-vivo bench test for bifurcation stenting with “StentBoost”
  154. Arrhythmogenic right ventricular dysplasia/cardiomyopathy presenting as ST-segment elevation myocardial infarction: A case report
  155. Re-examining minimal luminal diameter relocation and quantitative coronary angiography – intravascular ultrasound correlations in stented saphenous vein grafts: methodological
  156. First-in-man (FIM) study of the Stentys™ bifurcation stent – 30 days results
  157. The GENESIS (Randomized, Multicenter Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent System in Patients with De Novo Lesions of the Native Coronary Arteries) Trial
  158. 9-Month Clinical, Angiographic, and Intravascular Ultrasound Results of a Prospective Evaluation of the Axxess Self-Expanding Biolimus A9-Eluting Stent in Coronary Bifurcation Lesions
  159. Novel self‐expanding stent system for enhanced provisional bifurcation stenting: Examination by StentBoost and intravascular ultrasound
  160. Step‐by‐step StentBoost‐guided small vessel stenting using the self‐expandable sparrow stent‐in‐wire
  161. Percutaneous coronary implantation of sirolimus-eluting stents in unselected patients and lesions: Clinical results and multiple outcome predictors
  162. Drug eluting stents in patients with diabetes
  163. Comparison of Assessment of Native Coronary Arteries by Standard Versus Three-Dimensional Coronary Angiography
  164. Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention
  165. Last nail in the coffin of late lumen loss?
  166. Are Surrogate End Points in Drug-Eluting Stent Trials Reliable?
  167. Revisiting the role of percutaneous revascularization versus medical therapy for later infarct-related artery occlusion (letter of comment on Ioannidis and Katritsis. Am Heart J. 2007;154:1065-71)
  168. Reply
  169. Survival and Cardiac Remodeling Benefits in Patients Undergoing Late Percutaneous Coronary Intervention of the Infarct-Related Artery
  170. Successful percutaneous treatment of an intraprocedural left main stent thrombosis with the support of an automatic mechanical chest compression device
  171. “Trans‐collateral” angioplasty for a challenging chronic total occlusion of the tibial vessels: A novel approach to percutaneous revascularization in critical lower limb ischemia
  172. Ischemia Induced by Transesophageal Atrial Pacing Stress Echocardiography Predicts Long-Term Mortality
  173. Potentials and Pitfalls of Meta-analysis on Statins
  174. Making sense of the recent meta-analytical confusion concerning the safety of drug-eluting stents
  175. Appraising the effectiveness and safety of paclitaxel-eluting stents in over 1,000 very high-risk patients: overall results of the Taxus in Real-life Usage Evaluation (TRUE) registry
  176. Percutaneous coronary stenting in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis
  177. Meta-Analysis Appraising High Clopidogrel Loading in Patients Undergoing Percutaneous Coronary Intervention††Conflicts of interest: Dr. Angiolillo is a consultant and on the speaker’s bureau for Bristol Myers Squibb, New York, New York, and Sanofi-Aven...
  178. Letters to the Editor
  179. Acute and mid-term local vascular effects of compliant balloon inflation (GuardWire system) on saphenous vein bypass grafts: An angiographic analysis
  180. Increased Late Mortality After Sirolimus-Eluting Stents Versus Bare-Metal Stents in Diseased Saphenous Vein Grafts
  181. The direct thrombin inhibitor ximelagatran/melagatran: a systematic review on clinical applications and an evidence based assessment of risk benefit profile
  182. Intravascular Ultrasound Comparison of Sirolimus-Eluting Stent Versus Bare Metal Stent Implantation in Diseased Saphenous Vein Grafts (from the RRISC [Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent] Trial)
  183. Adjusted Indirect Meta-Analysis of Aspirin Plus Warfarin at International Normalized Ratios 2 to 3 Versus Aspirin Plus Clopidogrel After Acute Coronary Syndromes
  184. Comparable Clinical Outcomes With Paclitaxel- and Sirolimus-Eluting Stents in Unrestricted Contemporary Practice
  185. Letter of comment on “Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial” (Am Heart J...
  186. Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients
  187. Acute coronary syndromes: an emphasis shift from treatment to prevention; and the enduring challenge of vulnerable plaque detection in the cardiac catheterization laboratory
  188. Benefits of clopidogrel in patients undergoing coronary stenting significantly depend on loading dose: Evidence from a meta-regression
  189. Bifurcation stenting with a dedicated biolimus‐eluting stent: X‐ray visual enhancement of the final angiographic result with “stentboost subtract”
  190. Angiographic Analysis of Pattern of Late Luminal Loss in Sirolimus- and Paclitaxel-Eluting Stents
  191. Clinical Implications of the PROTECT–TIMI-30 Trial
  192. Direct and indirect comparison meta-analysis demonstrates the superiority of sirolimus- versus paclitaxel-eluting stents across 5854 patients
  193. Dissimilar relevance given to diseases by medical literature, and the potential to create biases in the clinical decision-making process: The case of late stent thrombosis
  194. Meta-Analysis of the Studies Assessing Temporal Changes in Coronary Plaque Volume Using Intravascular Ultrasound
  195. Randomized Double-Blind Comparison of Sirolimus-Eluting Stent Versus Bare-Metal Stent Implantation in Diseased Saphenous Vein Grafts
  196. Mastering the antegrade femoral artery access in patients with symptomatic lower limb ischemia: Learning curve, complications, and technical tips and tricks
  197. Macroscopic assessment of porcine coronary vessel wall trauma after percutaneous cardiac catheterization and intervention
  198. Diagnostic Performance of Multislice Spiral Computed Tomography of Coronary Arteries as Compared With Conventional Invasive Coronary Angiography
  199. Comparison of ticlopidine vs. clopidogrel in addition to aspirin after paclitaxel-eluting stent implantation: Insights from the TRUE (Taxus™ in Real-life Usage Evaluation) Study
  200. Is Late Luminal Loss an Accurate Predictor of the Clinical Effectiveness of Drug-Eluting Stents in the Coronary Arteries?
  201. Clinical effectiveness of bare-metal stenting compared with balloon angioplasty in total coronary occlusions: Insights from a systematic overview of randomized trials in light of the drug-eluting stent era
  202. Plasma levels of oxidized-low-density lipoproteins are higher in patients with unstable angina and correlated with angiographic coronary complex plaques
  203. The drug-eluting stent dilemma: comparing the effectiveness of Cypher versus Taxus
  204. Drawbacks of Nonrandomized Trials in Acute Coronary Syndromes
  205. Clinical Outcome Following Aleatory Implantation of Paclitaxel-Eluting or Sirolimus-Eluting Stents in Complex Coronary Lesions
  206. Should Degenerated Saphenous Vein Grafts Routinely Be Sealed with Drug‐Eluting Stents?
  207. In-vivo, cardiac-cycle related intimal displacement of coronary plaques assessed by 3-D ECG-gated intravascular ultrasound: exploring its correlate with tissue deformability identified by palpography
  208. Enhanced Plasma Levels of Oxidized Low-Density Lipoprotein Increase Circulating Nuclear Factor-Kappa B Activation in Patients With Unstable Angina
  209. Oral anticoagulants for the secondary prevention of coronary heart disease
  210. Validation of Predictors of Intraprocedural Stent Thrombosis in the Drug-Eluting Stent Era
  211. Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent-controlled trials
  212. Long-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: A metaregression
  213. Hibernating myocardium, apoptosis, and a simple mathematical task
  214. Coronary stenting versus balloon angioplasty in small vessels
  215. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures
  216. Acute myocardial infarction probably caused by paradoxical embolus in a pregnant woman
  217. Is vasopressin superior to adrenaline or placebo in the management of cardiac arrest? A meta-analysis
  218. Therapeutic efficiency of tirofiban in acute coronary syndromes